ARGX Competitors & Alternatives
Compare argenx NV ADR with similar stocks in the same industry
Biotechnology
ARGX
Main Stock$981.33
Tradestie Score
31
Market Cap
$46.96B
P/E Ratio
33.9
Revenue Growth
0.5%
Analyst Upside
+16.9%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals Inc
|
$542.62
|
$103.64B | 35.2 | 39 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$951.19
|
$63.59B | 21.2 | 32 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$156.65
|
$60.38B | 8.1 | 51 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$415.96
|
$36.81B | 53.8 | 30 | Compare |
|
INSM
Insmed, Inc.
|
$118.07
|
$31.13B | - | 37 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$85.04
|
$24.57B | - | 52 | Compare |
|
GMAB
Genmab A/S ADS
|
$51.74
|
$19.56B | 46.0 | 33 | Compare |
|
INCY
Incyte Genomics Inc
|
$121.70
|
$16.93B | 62.4 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$68.97
|
$15.70B | 45.8 | 40 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.08
|
$15.22B | - | 48 | Compare |
More ARGX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
217 stocks in this industry